{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:49:12Z","timestamp":1762458552637},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2007,5,31]],"date-time":"2007-05-31T00:00:00Z","timestamp":1180569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,5,31]],"date-time":"2007-05-31T00:00:00Z","timestamp":1180569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1038\/sj.leu.2404772","type":"journal-article","created":{"date-parts":[[2007,5,31]],"date-time":"2007-05-31T15:46:23Z","timestamp":1180626383000},"page":"2204-2206","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["BCR-ABLT315I transcript disappearance in an imatinib-resistant CML patient treated with homoharringtonine: a new therapeutic challenge?"],"prefix":"10.1038","volume":"21","author":[{"given":"L","family":"Legros","sequence":"first","affiliation":[]},{"given":"S","family":"Hayette","sequence":"additional","affiliation":[]},{"given":"F E","family":"Nicolini","sequence":"additional","affiliation":[]},{"given":"S","family":"Raynaud","sequence":"additional","affiliation":[]},{"given":"K","family":"Chabane","sequence":"additional","affiliation":[]},{"given":"J-P","family":"Magaud","sequence":"additional","affiliation":[]},{"given":"J-P","family":"Cassuto","sequence":"additional","affiliation":[]},{"given":"M","family":"Michallet","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2007,5,31]]},"reference":[{"key":"BF2404772_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1182\/blood-2006-01-0092","volume":"108","author":"T Hughes","year":"2006","unstructured":"Hughes T, Deininger M, Hochhaus A, Branford S, Radich J, Kaeda J et al. Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results. Blood 2006; 108: 28\u201337.","journal-title":"Blood"},{"key":"BF2404772_CR2","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1126\/science.1099480","volume":"305","author":"NP Shah","year":"2004","unstructured":"Shah NP, Tran C, Lee FY, Chen P, Norris D, Sawyers CL . Overriding imatinib resistance with a novel ABL kinase inhibitor. Science 2004; 305: 399\u2013401.","journal-title":"Science"},{"key":"BF2404772_CR3","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1182\/blood.V86.9.3322.bloodjournal8693322","volume":"86","author":"S O'Brien","year":"1995","unstructured":"O'Brien S, Kantarjian H, Keating M, Beran M, Koller C, Robertson LE et al. Homoharringtonine therapy induces responses in patients with chronic myelogenous leukemia in late chronic phase. Blood 1995; 86: 3322\u20133326.","journal-title":"Blood"},{"key":"BF2404772_CR4","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1182\/blood.V93.12.4149","volume":"93","author":"S O'Brien","year":"1999","unstructured":"O'Brien S, Kantarjian H, Koller C, Feldman E, Beran M, Andreeff M et al. Sequential homoharringtonine and interferon-alpha in the treatment of early chronic phase chronic myelogenous leukemia. Blood 1999; 93: 4149\u20134153.","journal-title":"Blood"},{"key":"BF2404772_CR5","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/sj.leu.2404236","volume":"20","author":"FE Nicolini","year":"2006","unstructured":"Nicolini FE, Corm S, Le QH, Sorel N, Hayette S, Bories D et al. Mutation status and clinical outcome of 89 imatinib mesylate-resistant chronic myelogenous leukemia patients: a retrospective analysis from the French intergroup of CML (Fi(phi)-LMC GROUP). Leukemia 2006; 20: 1061\u20131066.","journal-title":"Leukemia"},{"key":"BF2404772_CR6","doi-asserted-by":"crossref","unstructured":"Nicolini FE, Hayette S, Corm S, Bachy E, Bories D, Tulliez M et al. Clinical outcome of 27 imatinib mesylate resistant chronic myelogenous leukemia (CML) patients harbouring a T315I BCR-ABL mutation. Haematologica 2007, (in press).","DOI":"10.3324\/haematol.11369"},{"key":"BF2404772_CR7","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1182\/blood-2006-05-025049","volume":"109","author":"FJ Giles","year":"2007","unstructured":"Giles FJ, Cortes JE, Jones D, Bergstrom DA, Kantarjian HM, Freedman SJ . MK-0457, a novel kinase inhibitor, is active in patients with chronic myeloid leukemia or acute lymphocytic leukemia with the T315I BCR-ABL mutation. Blood 2007; 109: 500\u2013502.","journal-title":"Blood"},{"key":"BF2404772_CR8","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1038\/sj.leu.2403135","volume":"17","author":"J Gabert","year":"2003","unstructured":"Gabert J, Beillard E, van der Velden VH, Bi W, Grimwade D, Pallisgaard N et al. Standardization and quality control studies of \u2018real-time\u2019 quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia \u2013 a Europe Against Cancer program. Leukemia 2003; 17: 2318\u20132357.","journal-title":"Leukemia"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2404772.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404772","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404772.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T02:52:08Z","timestamp":1648781528000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2404772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,31]]},"references-count":8,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["BF2404772"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2404772","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,31]]},"assertion":[{"value":"31 May 2007","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}